| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $30K | -97.7% |
| R&D Expense | $20.3M | +10.3% |
| SG&A Expense | $940K | +55.9% |
| Operating Income | -$67.5M | -90.1% |
| Income Tax | $0 | — |
| Net Income | -$54.4M | -56.8% |
| EPS (Basic) | -$0.57 | +34.5% |
| EPS (Diluted) | -$0.57 | +34.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.0M | -66.3% |
| Short-term Investments | $157.4M | +146.4% |
| Current Assets | $231.7M | -16.6% |
| Total Assets | $233.2M | -17.1% |
| Current Liabilities | $2.4M | -56.1% |
| Total Liabilities | $2.4M | -71.6% |
| Stockholders' Equity | $230.8M | -15.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.3M | -47.9% |
| Capital Expenditures | $175K | -12.1% |
| Investing Cash Flow | -$87.2M | — |
| Financing Cash Flow | $6.9M | -96.4% |
| Free Cash Flow | -$59.4M | -47.6% |